Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.
Jubilant Pharmova secured USFDA approval for commercial batch manufacturing on Line 3 at its Spokane, USA contract facility. This green light for the new isolator-based fill and finish line boosts capacity and operational readiness, signaling enhanced business potential.